Product NDC: | 63459-542 |
Proprietary Name: | FENTORA |
Non Proprietary Name: | fentanyl citrate |
Active Ingredient(s): | 200 ug/1 & nbsp; fentanyl citrate |
Administration Route(s): | BUCCAL; ORAL; TRANSMUCOSAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 63459-542 |
Labeler Name: | Cephalon, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021947 |
Marketing Category: | NDA |
Start Marketing Date: | 20060925 |
Package NDC: | 63459-542-28 |
Package Description: | 7 BLISTER PACK in 1 CARTON (63459-542-28) > 4 TABLET in 1 BLISTER PACK (63459-542-04) |
NDC Code | 63459-542-28 |
Proprietary Name | FENTORA |
Package Description | 7 BLISTER PACK in 1 CARTON (63459-542-28) > 4 TABLET in 1 BLISTER PACK (63459-542-04) |
Product NDC | 63459-542 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | fentanyl citrate |
Dosage Form Name | TABLET |
Route Name | BUCCAL; ORAL; TRANSMUCOSAL |
Start Marketing Date | 20060925 |
Marketing Category Name | NDA |
Labeler Name | Cephalon, Inc. |
Substance Name | FENTANYL CITRATE |
Strength Number | 200 |
Strength Unit | ug/1 |
Pharmaceutical Classes | Full Opioid Agonists [MoA],Opioid Agonist [EPC] |